ARWR · Arrowhead Pharmaceuticals, Inc.

$87.47 -1.94 (-2.17%) At close · Aug 20

Market Cap

$12.36B

141.25M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Anzalone	President and Chief Executive Officer	$951,012	—	$10,319,000	—	$1,152,000	$1,461	$12,423,473
Patrick O’Brien	Chief Operating Officer and General Counsel	$605,259	—	$2,935,050	—	$378,000	$15,261	$3,933,570
Kenneth A. Myszkowski	Chief Financial Officer	$592,369	—	$2,589,750	—	$314,496	$15,761	$3,512,376
James Hamilton	Chief of Discovery and Translational Medicine	$567,937	—	$2,589,750	—	$314,496	$15,261	$3,487,444
Javier San Martin	Former Chief Medical Officer	$260,529	—	$2,589,750	—	—	$606,285	$3,456,564
Tracie Oliver	Former Chief Commercial Officer	$484,065	—	$2,589,750	—	—	$2,965	$3,076,780

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Anzalone	President and Chief Executive Officer	$902,522	—	$8,314,056	—	$700,000	$1,515	$9,918,093
Patrick O’Brien	Chief Operating Officer and General Counsel	$568,422	—	$2,475,200	—	$252,000	$14,715	$3,310,337
Kenneth A. Myszkowski	Chief Financial Officer	$568,128	—	$2,284,800	—	$252,000	$14,215	$3,119,143
Javier San Martin	Former Chief Medical Officer	$544,467	—	$2,284,800	—	$252,000	$14,715	$3,095,982
James Hamilton	Chief of Discovery and Translational Medicine	$511,178	—	$2,284,800	—	$236,250	$14,715	$3,046,943
Tracie Oliver	Former Chief Commercial Officer	$647,261	—	$19,040	—	$188,000	$19,521	$873,822

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Anzalone	President and Chief Executive Officer	$863,417	—	$10,382,549	—	$783,315	$2,688	$12,031,969
Kenneth A. Myszkowski	Chief Financial Officer	$509,648	—	$3,978,000	—	$238,106	$13,798	$4,739,552
Patrick O’Brien	Chief Operating Officer and General Counsel	$500,466	—	$3,978,000	—	$235,599	$13,798	$4,727,863
James Hamilton	Chief of Discovery and Translational Medicine	$450,436	—	$3,646,500	—	$212,580	$13,798	$4,323,314
Tracie Oliver	Former Chief Commercial Officer	$111,154	$16,344	$2,517,200	—	$94,874	$4,899	$2,744,471
Javier San Martin	Former Chief Medical Officer	$479,170	—	—	—	$225,574	—	$704,744

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Christopher Anzalone	President and Chief Executive Officer	$837,031	—	$23,019,000	—	$845,000	$2,824	$24,703,855
Patrick O’Brien	Chief Operating Officer and General Counsel	$479,762	—	$4,603,800	—	$239,630	$13,734	$5,336,926
Kenneth A. Myszkowski	Chief Financial Officer	$484,865	—	$4,603,800	—	$231,171	$13,734	$5,333,570
James Hamilton	Chief of Discovery and Translational Medicine	$426,109	—	$3,836,500	—	$233,604	$13,734	$4,509,947
Javier San Martin	Chief Medical Officer	$459,346	—	—	—	$185,400	—	$644,746
Tracie Oliver	Chief Commercial Officer	—	—	—	—	—	—	—

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce Given	COO	$409,615	—	$15,857,500	—	—	$76,693	$16,343,808
Bruce Given, M.D.	Former Chief Operating Officer	$409,615	—	$15,857,500	—	—	$76,693	$16,343,808
Christopher Anzalone	President and Chief Executive Officer	$785,625	—	$12,686,000	—	$820,000	$2,892	$14,294,517
James Hassard	Chief Commercial Officer	$302,404	—	$7,430,000	—	$170,000	$15,892	$7,918,296
Javier San Martin	Chief Medical Officer	$380,769	$100,000	$7,225,500	—	$180,000	$12,802	$7,899,071
Curt Bradshaw	Former Chief Scientific Officer	$338,462	—	$6,021,250	—	—	$13,494	$6,373,206
Kenneth A. Myszkowski	Chief Financial Officer	$463,750	—	$5,391,550	—	$213,750	$12,802	$6,081,852
Patrick O’Brien	Chief Operating Officer and General Counsel	$459,100	—	$4,440,100	—	$211,500	$12,802	$5,123,502
James Hamilton	Chief of Discovery and Translational Medicine	$376,362	—	$2,854,350	—	$169,363	$12,802	$3,412,877
Tracie Oliver	Chief Commercial Officer	—	$0	—	—	—	—	—

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce Given, M.D.	Former Chief Operating Officer	$488,750	—	$2,608,200	—	$850,000	$11,799	$3,958,759
Bruce Given	COO	$488,750	—	$2,608,200	—	$850,000	$11,799	$3,958,759
Curt Bradshaw	Former Chief Scientific Officer	—	—	—	—	—	—	—
James Hassard	Chief Commercial Officer	—	—	—	—	—	—	—
Javier San Martin	Chief Medical Officer	—	—	—	—	—	—	—

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Bruce Given, M.D.	Former Chief Operating Officer	$450,362	—	$644,000	—	$445,900	$11,799	$1,552,061
Bruce Given	COO	$450,362	—	$644,000	—	$445,900	$11,799	$1,552,061
Curt Bradshaw	Former Chief Scientific Officer	—	—	—	—	—	—	—
Javier San Martin	Chief Medical Officer	—	—	—	—	—	—	—
James Hassard	Chief Commercial Officer	—	—	—	—	—	—	—

Executive changes

Person	Role	Change	Effective	Filed
Dr. Matt Cohen, M.D., M.B.A.	director	Appointed	2026-06-12	2026-06-16
Daniel Apel	Chief Financial Officer	Appointed	2025-05-13	2025-04-15
Ken Myszkowski	Chief Financial Officer	Retired	2025-05-13	2025-04-15
Douglas Ingram	director	Appointed	2025-02-06	2025-02-07
Douglass Given, M.D., Ph.D.	Director	Retired	2024-12-31	2024-12-18
Douglass Given, M.D., Ph.D.	Chairman of the Board	Retired	2024-12-31	2024-12-18
Hongbo Lu	independent director	Appointed	2024-04-01	2024-02-22
Bruce Given, M.D.	Chief Medical Scientist	Appointed	—	2024-01-22
Marianne De Backer	director	Resigned	2023-04-02	2023-02-14
Patrick O'Brien	Chief Operating Officer and General Counsel	Appointed	2022-07-15	2022-07-20
Victoria Vakiener	independent director	Appointed	2022-05-02	2022-05-05
James Hassard	Chief Commercial Officer	Terminated	2021-08-23	2021-08-27
Oye Olukotun, M.D., MPH	independent director	Appointed	2020-09-01	2020-09-08

Key facts CIK 879407 CUSIP 04280A100 13F (30d) 458 filings 451 filers Visit website Investor relations